Skip to main content
. 2025 Jan 21;25:251. doi: 10.1186/s12889-025-21467-3

Table 2.

HIV incidence estimate for pregnant women aged [15–45) years based on method 1 (estimates incidence from prevalence under three scenarios of mortality) and on method 2 (estimates incidence from prevalence of survival information after HIV infection)

Calendar estimation point Prevalence Surveys (Year) Estimated incidence using Method 1 Estimated incidence
using Method 2
Early Stable Declining
2010.5 2010, 2011 6.23 [4.59—9.34] 6.63 [4.89—9.70] 7.27 [5.36—10.25] 7.16 [5.29—10.09]
2011.5 2011, 2012 29.09 [10.69—42.38] 29.42 [10.96—42.63] 29.92 [11.3—42.98] 29.53 [11.12—42.70]
2014.5 2012, 2016 2.71 [1.48 – 6.00] 2.95 [1.62—6.27] 3.65 [1.88—6.74] 3.83 [2.01—6.75]
2016.5 2016, 2017 8.43 [5.29—12.16] 8.8 [5.61—12.51] 9.36 [6.13—13.05] 9.23 [6.07—12.87]
2017.5 2017, 2018 7.08 [5.14—9.97] 7.58 [5.51—10.44] 8.35 [6.14—11.12] 8.06 [5.93—10.79]
2018.5 2018, 2019 9.01 [6.75—12.28] 9.43 [7.13—12.7] 10.16 [7.76—13.35] 9.98 [7.65—13.13]
2019.5 2019, 2020 5.24 [3.68—8.49] 5.65 [3.97—8.89] 6.32 [4.54—9.55] 6.09 [4.38—9.25]
2020.5 2020, 2021 5.46 [3.88—7.96] 5.79 [4.15—8.28] 6.30 [4.60—8.78] 6.07 [4.43—8.51]

The incidence was calculated as weighted mean of the age-group incidences, with weights based on age-group sample size: per 100 person-years (95% CI interval). The three scenarios: early (defined as epidemics that are still expanding), stable (epidemics that have stopped expanding) and declining epidemic (epidemics that are in decline)